Follow-The-Filings

Holders · period archive

CSTL · Castle Biosciences Inc

Q2 2026 13F holders among managers we track latest ownership dossier

Ticker
CSTL
Type
Equity
Class
COMMON STOCK
Total reported value ($000, long equity)
Manager Report date Value Shares